Concepedia

Brooke Bollman

BB

Statistics

Publications

3

Citations

200

H-Index

3

Active since

2022

Affiliations

Moderna Therapeutics (United States)(Current)

National Institute of Allergy and Infectious Diseases

Takeda (United States)

National Institutes of Health

Brooke Bollman is an author at Moderna Therapeutics (United States) specializing in vaccine safety, vaccination, and flavivirus.

ORCID

Top concepts

Publications per year

2022–2023

3

Publications

3

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

Brandon Essink, Laurence Chu, William Seger et al. · The Lancet Infectious Diseases · 2023 · 129 citations

, , +8

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

Brooke Bollman, Naveen Nunna, Kapil Bahl et al. · npj Vaccines · 2023 · 56 citations · Full text

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

Brooke Bollman, Naveen Nunna, Kapil Bahl et al. · 2022 · 15 citations · Full text

1–3 of 3